Tumor suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma (vol 12, pg 1421, 2017)

被引:0
|
作者
Kao, S. C.
Cheng, Y. Y.
Williams, M.
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:587 / 587
页数:1
相关论文
共 50 条
  • [1] Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma
    Kao, Steven C.
    Cheng, Yuen Yee
    Williams, Marissa
    Kirschner, Michaela B.
    Madore, Jason
    Lum, Trina
    Sarun, Kadir H.
    Linton, Anthony
    McCaughan, Brian
    Klebe, Sonja
    van Zandwijk, Nico
    Scolyer, Richard A.
    Boyer, Michael J.
    Cooper, Wendy A.
    Reid, Glen
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (09) : 1421 - 1433
  • [2] Multiple Mechanisms Contribute to Downregulation of Tumor Suppressor microRNAs in Malignant Pleural Mesothelioma
    Williams, M.
    Kirschner, M.
    Cheng, Y. Y.
    Sarun, K.
    Mccaughan, B.
    Kao, S.
    Van Zandwijk, N.
    Reid, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1885 - S1885
  • [3] Prognostic impact of PD-L1 and PD-L2 expression in malignant pleural mesothelioma
    Yagci, S.
    Tepeoglu, M.
    Canpolat, E.
    Bayik, P.
    Kilic, M.
    Ozdemir, B. H.
    [J]. VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S334 - S334
  • [4] Prognostic Role of PD-L1 in Malignant Pleural Mesothelioma: Unraveling the Complexity of the Tumor Microenvironment in Mesothelioma
    de Perrot, Marc
    [J]. ANNALS OF THORACIC SURGERY, 2021, 112 (05): : 1583 - 1584
  • [5] Four Immunohistochemical Assays to Measure the PD-L1 Expression in Malignant Pleural Mesothelioma
    Watanabe, T.
    Okuda, K.
    Moriyama, S.
    Haneda, H.
    Yokota, K.
    Tatematsu, T.
    Sakane, T.
    Oda, R.
    Nakanishi, R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S757 - S757
  • [6] PD-L1 expression associated with worse survival outcome in malignant pleural mesothelioma
    Nguyen, Bella Hai
    Montgomery, Renn
    Fadia, Mitali
    Wang, Jiali
    Ali, Sayed
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (01) : 69 - 73
  • [7] VISTA is Highly Expressed in Malignant Pleural Mesothelioma (MPM) and Independent of PD-L1 Expression
    Zauderer, M.
    Muller, S.
    Lai, W.
    Ni, A.
    Jungbluth, A.
    Ginsberg, M.
    Daly, R.
    Hellmann, M.
    Ladanyi, M.
    Sauter, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S758 - S758
  • [8] Integrating PD-L1 Expression to the CALGB Prognostic Scoring System in Malignant Pleural Mesothelioma
    Cabrera, L. A.
    Aviles-Salas, A.
    Hernandez-Pedro, N.
    Orozco-Morales, M.
    Motola-Kuba, D.
    Munoz, W.
    Ramos-Ramirez, M.
    Heredia, D.
    Lara-Mejia, L.
    Soberanis-Pina, P. D.
    Corrales, L.
    Martin, C.
    Cardona, A. F.
    Arrieta, O.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S317 - S318
  • [9] PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesothelioma
    Aviles-Salas, Alejandro
    Cabrera-Miranda, Luis
    Hernandez-Pedro, Norma
    Vargas-Lias, Diana Sofia
    Samtani, Suraj
    Munoz-Montano, Wendy
    Motola-Kuba, Daniel
    Corrales-Rodriguez, Luis
    Martin, Claudio
    Cardona, Andres F.
    Palomares-Palomares, Cittim B.
    Arrieta, Oscar
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [10] Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study
    Brcic, Luka
    Klikovits, Thomas
    Megyesfalvi, Zsolt
    Mosleh, Berta
    Sinn, Katharina
    Hritcu, Richard
    Laszlo, Viktoria
    Cufer, Tanja
    Rozman, Ales
    Kern, Izidor
    Mohorcic, Katja
    Jakopovic, Marko
    Samarzija, Miroslav
    Seiwerth, Sven
    Kolek, Vitezslav
    Fischer, Ondrej
    Jakubec, Petr
    Skarda, Jozef
    Gieszer, Balazs
    Hegedus, Balazs
    Fillinger, Janos
    Renyi-Vamos, Ferenc
    Buder, Anna
    Bilecz, Agnes
    Berger, Walter
    Grusch, Michael
    Hoetzenecker, Konrad
    Klepetko, Walter
    Hoda, Mir Alireza
    Filipits, Martin
    Dome, Balazs
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (04) : 1594 - 1607